Rakesh K Singh Selected Research

Interleukin-8B Receptors

1/2020	IL-17-CXC Chemokine Receptor 2 Axis Facilitates Breast Cancer Progression by Up-Regulating Neutrophil Recruitment.
3/2019	CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis.
4/2010	Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma.
2/2006	Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma.
1/2004	Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatic phenotype.
1/2003	Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rakesh K Singh Research Topics

Disease

92	Neoplasms (Cancer) 01/2022 - 11/2002
38	Neoplasm Metastasis (Metastasis) 02/2021 - 01/2003
23	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 05/2008
19	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2008
12	Melanoma (Melanoma, Malignant) 12/2012 - 04/2002
11	Neuroblastoma 01/2022 - 10/2007
10	Infections 10/2020 - 01/2005
9	Leishmaniasis 05/2020 - 01/2009
7	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 09/2010
7	Endometrial Neoplasms (Endometrial Cancer) 01/2020 - 07/2011
5	COVID-19 01/2022 - 10/2020
5	Inflammation (Inflammations) 01/2022 - 01/2005
5	Carcinogenesis 01/2020 - 01/2014
5	Osteolysis 05/2010 - 07/2008
4	Visceral Leishmaniasis (Kala Azar) 01/2021 - 10/2012
4	Neuroinflammatory Diseases 01/2020 - 01/2018
4	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 01/2007
4	Hypercalcemia (Milk Alkali Syndrome) 10/2014 - 11/2011
3	Myocarditis (Carditis) 11/2021 - 03/2016
3	Type 2 Diabetes Mellitus (MODY) 05/2018 - 05/2009
3	Heart Failure 12/2016 - 08/2013
3	Hypoxia (Hypoxemia) 10/2015 - 09/2002
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2004
2	Multiple Organ Failure (MODS) 01/2022 - 11/2020
2	Ischemic Stroke 03/2021 - 07/2017
2	Heart Diseases (Heart Disease) 11/2020 - 03/2016
2	Hypertrophy 01/2020 - 01/2020
2	Tuberculosis (Tuberculoses) 01/2020 - 09/2017
2	Arthritis (Polyarthritis) 01/2020 - 06/2019
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2017 - 08/2013
2	Congenital Heart Defects (Congenital Heart Defect) 04/2017 - 02/2012

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2002
19	Pharmaceutical PreparationsIBA 01/2020 - 03/2007
15	Messenger RNA (mRNA)IBA 01/2022 - 09/2002
15	LigandsIBA 01/2022 - 01/2003
12	CytokinesIBA 01/2021 - 04/2005
10	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2005
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2014
9	Chemokine ReceptorsIBA 01/2021 - 04/2010
9	ChemokinesIBA 01/2021 - 03/2003
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 09/2002
6	Interleukin-8B ReceptorsIBA 01/2020 - 01/2003
6	Interleukin-8 (Interleukin 8)IBA 01/2020 - 04/2002
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015 - 09/2002
6	PlatinumIBA 06/2014 - 05/2008
5	VaccinesIBA 11/2021 - 09/2012
5	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020 - 02/2010
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 07/2011
5	Cisplatin (Platino)FDA LinkGeneric 07/2019 - 02/2011
5	Transforming Growth Factor beta (TGF-beta)IBA 09/2017 - 01/2009
4	PolymersIBA 01/2022 - 07/2013
4	Semaphorins (Semaphorin)IBA 02/2021 - 09/2010
4	AntigensIBA 01/2021 - 04/2005
4	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 04/2008
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 05/2013
4	AlkaloidsIBA 05/2018 - 01/2009
4	tetrathiomolybdate (ammonium tetrathiomolybdate)IBA 11/2015 - 05/2011
4	CopperIBA 10/2015 - 09/2009
4	Ergocalciferols (Ergocalciferol)FDA LinkGeneric 11/2013 - 07/2011
4	Vitamin D FDA LinkGeneric 11/2013 - 07/2011
4	Cathepsin GIBA 02/2010 - 07/2008
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 04/2016
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 09/2012
3	CholesterolIBA 01/2021 - 05/2018
3	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2017
3	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2018
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2019 - 01/2018
3	MicellesIBA 01/2019 - 03/2015
3	Biological ProductsIBA 03/2016 - 05/2008
3	AntioxidantsIBA 05/2015 - 07/2011
3	Vascular Endothelial Growth Factor CIBA 01/2015 - 10/2005
3	ethyl isothiocyanateIBA 08/2012 - 11/2007
3	7-methyl-indole ethyl isothiocyanateIBA 08/2012 - 11/2007
3	indoleIBA 08/2012 - 11/2007
3	p38 Mitogen-Activated Protein KinasesIBA 04/2012 - 08/2010
3	Iron(III)-salopheneIBA 04/2011 - 05/2008
3	RANK LigandIBA 01/2011 - 07/2008
3	Calcifediol (Calcidiol)FDA Link 10/2010 - 10/2007
3	Matrix Metalloproteinases (MMPs)IBA 05/2010 - 05/2003
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2022 - 10/2014
2	plexinIBA 02/2021 - 01/2007
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2009
2	Peptides (Polypeptides)IBA 01/2020 - 01/2007
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 10/2015
2	LuciferasesIBA 05/2018 - 07/2013
2	Caspase 3 (Caspase-3)IBA 09/2017 - 11/2015
2	Troponin CIBA 04/2017 - 10/2015
2	Protein Isoforms (Isoforms)IBA 12/2016 - 02/2016
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2016 - 07/2013

Therapy/Procedure

39	Therapeutics 04/2022 - 03/2007
13	Drug Therapy (Chemotherapy) 01/2021 - 08/2007
3	Immunotherapy 01/2021 - 08/2009
3	Heart Transplantation (Grafting, Heart) 11/2017 - 07/2013
2	RNAi Therapeutics 01/2022 - 01/2021
2	Thrombectomy 03/2021 - 07/2017
2	Resistance Training 01/2020 - 01/2020
2	Extracorporeal Membrane Oxygenation 01/2020 - 02/2012
2	Mechanical Ventilators (Ventilator) 04/2017 - 02/2012